Bio-Rad Laboratories Inc. CI A (BIO): Price and Financial Metrics

BIO POWR Grades

• BIO scores best on the Sentiment dimension, with a Sentiment rank ahead of 93.05% of US stocks.
• The strongest trend for BIO is in Growth, which has been heading up over the past 177 days.
• BIO ranks lowest in Momentum; there it ranks in the 1st percentile.

BIO Stock Summary

• BIO-RAD LABORATORIES INC's stock had its IPO on January 1, 1986, making it an older stock than 93.53% of US equities in our set.
• With a year-over-year growth in debt of 512.16%, BIO-RAD LABORATORIES INC's debt growth rate surpasses 96.46% of about US stocks.
• Over the past twelve months, BIO has reported earnings growth of -191.28%, putting it ahead of only 8.27% of US stocks in our set.
• Stocks that are quantitatively similar to BIO, based on their financial statements, market capitalization, and price volatility, are PHG, UPC, TARO, RDY, and AVGR.
• BIO's SEC filings can be seen here. And to visit BIO-RAD LABORATORIES INC's official web site, go to www.bio-rad.com.

BIO Valuation Summary

• BIO's price/sales ratio is 4.9; this is 139.02% higher than that of the median Healthcare stock.
• Over the past 243 months, BIO's price/sales ratio has gone up 3.9.

Below are key valuation metrics over time for BIO.

BIO Growth Metrics

Its 4 year net cashflow from operations growth rate is now at 184.96%.
• Its year over year net cashflow from operations growth rate is now at -5.89%.
• Its year over year net income to common stockholders growth rate is now at -102.47%.

Over the past 33 months, BIO's revenue has gone up $493,071,000.

The table below shows BIO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	2,804.73	261.951	-6,034.688
2022-06-30	2,870.979	484.8	-1,942.423
2022-03-31	2,895.811	589.226	-101.125
2021-12-31	2,922.545	656.521	4,245.902
2021-09-30	2,979.615	783.331	6,658.663
2021-06-30	2,879.829	688.632	4,045.454

BIO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• BIO has a Quality Grade of B, ranking ahead of 77.91% of graded US stocks.
• BIO's asset turnover comes in at 0.192 -- ranking 66th of 75 Measuring and Control Equipment stocks.
• AATC, HTGM, and WAT are the stocks whose asset turnover ratios are most correlated with BIO.

The table below shows BIO's key quality metrics over time.